SPARC net loss widens to Rs 9.40 crore in Q4

Sun Pharma Advanced Research Company (SPARC) today reported a net loss of Rs 9.40 crore for the fourth quarter ended March 31, 2015.
The company had reported a net loss of Rs 2.51 crore for the fourth quarter of last fiscal, SPARC said in a BSE filing.
Total income of the company decreased to Rs 43.13 crore in the quarter ended March 31, 2015 compared with Rs 45.21 crore in the corresponding period last fiscal.
For the year ended March 2015, the company reported a net loss of Rs 39.52 crore as against a net profit of Rs 30.32 crore for the year ended March 2014.

SPARC's total income decreased to Rs 158.77 crore for the year ended March 2015 from Rs 177.03 crore in the corresponding period last year.
SPARC was demerged from Sun Pharma as a research and drug discovery company in 2007.
Shares of Sun Pharma Advanced Research Company closed 1.47 per cent up at Rs 412 apiece on the BSE.